Maggie Chen
Maggie is a scientist and science journalist covering health, biology, and bioengineering. She graduated from Harvard College in 2022 with a degree in developmental biology and the history of science. Her writing has appeared in the New York Times, WIRED, Massive Science, and Lady Science. She enjoys watching heart cells beat under a microscope, designing children’s books, and making brunch.
Articles by Maggie Chen
| 6 min read
Enzyme replacement therapy has been the mainstay of Pompe disease. New and emerging therapies may provide more options for patients.
| 3 min read
Ovarian tumors are extremely difficult to get rid of. Scientists are figuring out how to leverage the immune system to help.
| 3 min read
Two mutations in the BRCA1 gene greatly increase the risk of breast cancer. Now, it seems that only one mutation can help cells tip toward a cancerous edge.
| 4 min read
In some kids, an RSV infection is mild, while others are hospitalized. Natural killer cells might be the reason why.
| 3 min read
Doctors have been treating bacterial vaginosis with the same antibiotic for decades. This fatty acid could change that.
| 4 min read
Previous genome editing techniques only work when delivered early in life. This approach could help preserve hearing that is lost later on.
| 5 min read
Many diseases cause proteins to go haywire. Scientists are now developing drug molecules to change that.
Gene therapy has a complicated history, marked by many ups and downs and crafted by ever-advancing technologies.
| 6 min read
Viral diseases like hepatitis don’t have many successful treatments available, so scientists are engineering antibodies to try and change that.
| 6 min read
For decades, researchers have tried to craft a successful vaccine for HIV. mRNA vaccines may offer the answer.
| 3 min read
Scientists created a pill that, when swallowed, collects snapshots of the gastrointestinal microbiome, revealing striking differences along the GI tract.
Scientists harnessed the prokaryotic immune system to develop a groundbreaking gene editing technology that improves human health.
Through many innovations over the past 40 years, ChIP rapidly evolved to become a powerful tool for understanding the epigenome.
Through many innovations over the past 40 years, ChIP rapidly evolved to become a powerful tool for understanding the epigenome.
Following innovations in amplification and scaling over the past 30 years, single cell sequencing technologies have permeated all corners of biomedical research, providing cellular insights into diseases such as heart failure or the immune response during COVID-19 infection.
Page 1 of 2 - 16 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Reliable fluid biomarkers strategies for clinical neuroscience research
Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
Understanding drug impurities: types, sources, and analytical strategies
Unseen and often unexpected, drug impurities can slip in at every drug development stage, making their detection and control essential.
Discovering cutting-edge nitrosamine analysis in pharmaceuticals
New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
